𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial

✍ Scribed by Kim, Edward S; Neubauer, Marcus; Cohn, Allen; Schwartzberg, Lee; Garbo, Lawrence; Caton, John; Robert, Francisco; Reynolds, Craig; Katz, Terry; Chittoor, Sreeni; Simms, Lorinda; Saxman, Scott

Book ID
121651938
Publisher
The Lancet
Year
2013
Tongue
English
Weight
283 KB
Volume
14
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Androgen-deprivation therapy alone or wi
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial
✍ Gravis, Gwenaelle; Fizazi, Karim; Joly, Florence; Oudard, StΓ©phane; Priou, Franc πŸ“‚ Article πŸ“… 2013 πŸ› The Lancet 🌐 English βš– 387 KB

## Background: Early chemotherapy might improve the overall outcomes of patients with metastatic non-castrate (ie, hormone-sensitive) prostate cancer. we investigated the effects of the addition of docetaxel to androgen-deprivation therapy (adt) for patients with metastatic non-castrate prostate ca